Topics
Glioblastoma | Treatment | Side effects | Epilepsy
Home > Publications > Topics > Glioblastoma > Treatment > Side effects > Epilepsy
Stritzelberger
J, Gesmann A, Fuhrmann I, Uhl M, Brandner S, Welte TM, Schembs L,
Dörfler A, Coras R, Adler W, Schwab S, Putz F, Fietkau R,
Distel L, Hamer H.
The
course of tumor-related epilepsy in glioblastoma patients: A
retrospective analysis.
Epilepsy
Behav.
2024 Jun 27;158:109919. doi:
10.1016/j.yebeh.2024.109919. PMID:
38941953. Observational study. ˍ
Yamada K, Matsuda R, Sasaki R, Maeoka R, Nakazawa T, Morimoto T,
Morisaki Y, Yokoyama S, Kotsugi M, Takeshima Y, Yamada S,
Nishimura F, Park YS, Nakagawa I.
Postoperative
Seizures Can Predict Overall Survival of Patients With Newly
Diagnosed Supratentorial Isocitrate Dehydrogenase-Wild
Glioblastoma Treated With Radiotherapy Plus Concomitant and
Adjuvant Temozolomide.
Brain
Tumor Res Treat. 2025 Oct 31;13(4):140-146. doi:
10.14791/btrt.2025.0022. PMID:
41218815. Observational study. ˍ
Dimova L, Stritzelberger J, Dimov D, Ort J, Hamou HA, Clusmann H,
Schnell O, Hamer H, Putz F, Corradini S, Singer L, Dörfler A,
Ricklefs F, Drexler R, Simon M, Heiland DH, Delev D.
Tumor-associated
epilepsy at diagnosis in glioblastoma patients reveals an
inflammatory molecular signature and is associated with better
overall survival.
Neuro
Oncol. 2026 Jun 19:noag134. doi:
10.1093/neuonc/noag134. PMID:
42320046˰ ˍ